Affordability and accessibility of various therapies particularly quick-relief medications; retail pharmacies & drug stores lucrative segments notably for over-the-counter painkillers Wilmington, Delaware, United States, June 24, 2022 (GLOBE NEWSWIRE) — Recent insights on the chronic pelvic pain treatment market highlight the trend of expanding array of therapies and medications including chiropractic care, acupuncture, biofeedback therapy, and cognitive behavioral therapy. Widespread adoption of pain relief medications continues to fuel sales of chronic pelvic pain treatment market. The global chronic pelvic pain treatment market is projected to surpass value of US$ 8 Bn by the end of the forecast period of 2022–2031. The commercialization of medications and/or cause-directed therapies has allowed each leading company to grow market share for chronic pelvic pain treatment products. Advances in diagnosis of chronic pelvic pain are reinforcing the market value of the chronic pelvic pain treatment products. The expansion of the chronic pelvic pain treatment market is thus being propelled by the availability of effective management strategies. The demand for OTC pain relievers, NSAIDs, and many non-opioid pain medications is expected to propel revenue streams for pharmaceutical companies in the chronic pelvic pain treatment market. Growing awareness about the range of treatment and management options available for chronic pelvic pain (CPP) is likely to catalyze lucrative opportunities in the near future. Request Brochure of Chronic Pelvic Pain Treatment Market Research Report – https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=84850 Key Findings of Chronic Pelvic Pain Treatment Market Study

• Massive Adoption of OTC Medications Propelling Revenue Growth: The use of pain relief medications, both OTC and prescribed, has spurred the revenue prospects in the chronic pelvic pain treatment market. Of note, the chronic pelvic pain treatment market has witnessed stable revenue opportunities from high preference for OTC medications. The demand has been bolstered by accessibility in retail pharmacies & drug stores. The study found that the medications segment held a major share of the global chronic pelvic pain treatment market with about 70% in 2021.